Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
The Efficacy of the Smart Pass Filter to Reduce the Risk for Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks From Myopotential Interference
Medical University of South Carolina
71 participants
Nov 6, 2023
INTERVENTIONAL
Conditions
Summary
This study is enrolling participants who are already implanted with a S-ICD device ( subcutaneous ICD), and are undergoing a routine outpatient clinic follow up appointment to have their S-ICD checked. The aim of the study is to see if a feature in the device can recognize muscle movement and differentiate movement from irregular heart signals. The study involves doing some simple arm exercises while collecting device data, both with this feature turn on and then with it turned off. Participants will be randomized to either have the feature turned on or off initially then it will be programmed the alternative way and the same exercise testing will be repeated. The study will involve just one visit.
Eligibility
Inclusion Criteria2
- At least 18 years of age
- Implanted EMBLEM S-ICD (Model A 209 and Model A 219, Boston Scientific, St Paul, MN, USA)
Exclusion Criteria3
- Less than 18 years of age
- Hemodynamically unstable
- Inability to preform TET due to orthopedic issues or cognitive impairment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Smart Pass filter will be programmed ON in the S-ICD while performing exercise testing.
Smart Pass filter will be programmed OFF in the S-ICD while performing exercise testing.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05766943